SCHEMBL4103188

SCHEMBL4103188

CCCc1nc(N)nc2ccc(-c3cccc4c3oc3ccccc34)nc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.36
ALOX5 P09917 2/20 0.35
KDM4E B2RXH2 2/20 0.34
TLR8 Q9NR97 1/20 0.34
TLR7 Q9NYK1 1/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PRKDC P78527 1/20 0.33
ALDH1A1 P00352 2/20 0.33
HRH4 Q9H3N8 2/20 0.33
GGPS1 O95749 1/20 0.33
HPGD P15428 1/20 0.33
GLA P06280 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
APP P05067 1/20 0.33
DHFR P00374 1/20 0.32
LIMK1 P53667 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
POLB P06746 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4107973 0.85 MPO (0.39) ALOX5TLR8TLR7PIK3CDPIK3CB
SCHEMBL4097695 0.84 TLR8 (0.41) KDM4ETLR8ALDH1A1HPGDAPP
SCHEMBL4097541 0.80 ADORA2A (0.45) ALOX5HRH4
SCHEMBL4106980 0.77 TLR8 (0.37) ALOX5KDM4ETLR8TLR7ALDH1A1
SCHEMBL4107650 0.77 HTR2A (0.43) TLR8TLR7DHFR
SCHEMBL4102859 0.77 CHRNA7 (0.40) TLR8TLR7APPDHFR
SCHEMBL4112229 0.76 PRKCZ (0.40) TLR8TLR7APPDHFR
SCHEMBL4096296 0.76 DHFR (0.36) TLR8TLR7DHFR
SCHEMBL4105834 0.76 DHFR (0.34) TLR8TLR7DHFR
SCHEMBL4102879 0.76 SSTR3 (0.38) KDM4ETLR8TLR7ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338435-B2 Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections GILEAD SCIENCES, INC. (US) 2012-12-25 US claimed
US-20090253696-A1 SUBSTITUTED PYRIDO(3,2-D) PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC. 2009-10-08 US claimed
WO-2008009076-A2 SUBSTITUTED PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC. (US) 2008-01-24 WO claimed
US-8338435-B2 Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections GILEAD SCIENCES, INC. (US) 2012-12-25 US disclosed
US-20090253696-A1 SUBSTITUTED PYRIDO(3,2-D) PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC. 2009-10-08 US disclosed
WO-2008009076-A2 SUBSTITUTED PYRIDO(3,2-D)PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS GILEAD SCIENCES, INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253696-A1 SUBSTITUTED PYRIDO(3,2-D) PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING VIRAL INFECTIONS PNPO, PNP, DPYD PDE10A 1859/4885ALOX5 498/4885KDM4E 2414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.